Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company ...

Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its ...

Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

David Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Amgen Inc. (NASDAQ: AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company announced full results from Part 1 of the Phase 2 study of MariTide ...

MariTide isn't approved, but even if it is, if it doesn't shake concerns related to side effects, then there may not be strong demand for it. Has Amgen become a bad buy on this news?

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new GLP-1 hits the market.